Sen. Bumpers Aims to Raise Health Research $$ With Cuts to Space Station, Supercollider, SDI
In Brief: New York Legislature Votes $240 Mil. Bond Issue For Roswell Park Construction; Kripke Honored
FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction
Adamson, Henney Chair Silicone Task Force
FDA Publishes Parallel Track Rules, Accelerated Drug Approval Initiative
President’s Cancer Panel Special Commission On Breast Cancer Named
NCI, Private Groups, Promote Mammograms To Blacks, Hispanics
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
